Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease

被引:271
作者
Chetelat, Gael [1 ,2 ,3 ,4 ]
La Joie, Renaud [1 ,2 ,3 ,4 ]
Villain, Nicolas [1 ,2 ,3 ,4 ]
Perrotin, Audrey [1 ,2 ,3 ,4 ]
de La Sayette, Vincent [1 ,2 ,3 ,4 ,5 ]
Eustache, Francis [1 ,2 ,3 ,4 ]
Vandenberghe, Rik [6 ,7 ,8 ]
机构
[1] INSERM, U1077, Caen, France
[2] Univ Caen Basse Normandie, UMR S1077, Caen, France
[3] Ecole Prat Hautes Etud, UMR S1077, Caen, France
[4] CHU Caen, U1077, F-14000 Caen, France
[5] CHU Caen, Serv Neurol, F-14000 Caen, France
[6] Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium
[7] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium
[8] Univ Leuven, KU Leuven, Alzheimer Res Ctr, Leuven Inst Neurosci & Dis, Leuven, Belgium
关键词
Amyloid PET imaging; Cognitively normal elderly; Preclinical Alzheimer's disease; Subjective cognitive decline; ApoE4; Longitudinal studies; POSITRON-EMISSION-TOMOGRAPHY; FLORBETAPIR F 18; BETA-PEPTIDE DEPOSITION; NORMAL OLDER-ADULTS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; MEMORY PERFORMANCE; FAMILY-HISTORY; GENETIC RISK;
D O I
10.1016/j.nicl.2013.02.006
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Recent developments of PET amyloid ligands have made it possible to visualize the presence of A beta deposition in the brain of living participants and to assess the consequences especially in individuals with no objective sign of cognitive deficits. The present review will focus on amyloid imaging in cognitively normal elderly, asymptomatic at-risk populations, and individuals with subjective cognitive decline. It will cover the prevalence of amyloid-positive cases amongst cognitively normal elderly, the influence of risk factors for AD, the relationships to cognition, atrophy and prognosis, longitudinal amyloid imaging and ethical aspects related to amyloid imaging in cognitively normal individuals. Almost ten years of research have led to a few consensual and relatively consistent findings: some cognitively normal elderly have A beta deposition in their brain, the prevalence of amyloid-positive cases increases in at-risk populations, the prognosis for these individuals is worse than for those with no A beta deposition, and significant increase in A beta deposition over time is detectable in cognitively normal elderly. More inconsistent findings are still under debate; these include the relationship between A beta deposition and cognition and brain volume, the sequence and cause-to-effect relations between the different AD biomarkers, and the individual outcome associated with an amyloid positive versus negative scan. Preclinical amyloid imaging also raises important ethical issues. While amyloid imaging is definitely useful to understand the role of A beta in early stages, to define at-risk populations for research or for clinical trial, and to assess the effects of anti-amyloid treatments, we are not ready yet to translate research results into clinical practice and policy. More researches are needed to determine which information to disclose from an individual amyloid imaging scan, the way of disclosing such information and the impact on individuals and on society. (C) 2013 The Authors. Published by Elsevier Inc.
引用
收藏
页码:356 / 365
页数:10
相关论文
共 119 条
  • [71] Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269
  • [72] Increased fibrillar amyloid-β burden in normal individuals with a family history of late-onset Alzheimer's
    Mosconi, Lisa
    Rinne, Juha O.
    Tsui, Wai H.
    Berti, Valentina
    Li, Yi
    Wang, Huiyu
    Murray, John
    Scheinin, Noora
    Nagren, Kjell
    Williams, Schantel
    Glodzik, Lidia
    De Santi, Susan
    Vallabhajosula, Shankar
    de Leon, Mony J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (13) : 5949 - 5954
  • [73] Aβ amyloid deposition in the language system and how the brain responds
    Nelissen, Natalie
    Vandenbulcke, Mathieu
    Fannes, Katrien
    Verbruggen, Alfons
    Peeters, Ronald
    Dupont, Patrick
    Van Laere, Koen
    Borman, Guy
    Vandenberghe, Rik
    [J]. BRAIN, 2007, 130 : 2055 - 2069
  • [74] Oh H., HUMAN BRAIN MAPPING
  • [75] Effects of age and β-amyloid on cognitive changes in normal elderly people
    Oh, Hwamee
    Madison, Cindee
    Haight, Thaddeus J.
    Markley, Candace
    Jagust, William J.
    [J]. NEUROBIOLOGY OF AGING, 2012, 33 (12) : 2746 - 2755
  • [76] Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
    Okello, A.
    Koivunen, J.
    Edison, P.
    Archer, H. A.
    Turkheimer, F. E.
    Nagren, K.
    Bullock, R.
    Walker, Z.
    Kennedy, A.
    Fox, N. C.
    Rossor, M. N.
    Rinne, J. O.
    Brooks, D. J.
    [J]. NEUROLOGY, 2009, 73 (10) : 754 - 760
  • [77] Subjective Cognition and Amyloid Deposition Imaging A Pittsburgh Compound B Positron Emission Tomography Study in Normal Elderly Individuals
    Perrotin, Audrey
    Mormino, Elizabeth C.
    Madison, Cindee M.
    Hayenga, Amynta O.
    Jagust, William J.
    [J]. ARCHIVES OF NEUROLOGY, 2012, 69 (02) : 223 - 229
  • [78] Alzheimer's disease: progress in prediction
    Petersen, Ronald C.
    [J]. LANCET NEUROLOGY, 2010, 9 (01) : 4 - 5
  • [79] β-amyloid imaging and memory in non-demented individuals:: evidence for preclinical Alzheimer's disease
    Pike, Kerryn E.
    Savage, Greg
    Villemagne, Victor L.
    Ng, Steven
    Moss, Simon A.
    Maruff, Paul
    Mathis, Chester A.
    Klunk, William E.
    Masters, Colin L.
    Rowe, Christopher C.
    [J]. BRAIN, 2007, 130 : 2837 - 2844
  • [80] Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
    Pike, Kerryn E.
    Ellis, Kathryn A.
    Villemagne, Victor L.
    Good, Norm
    Chetelat, Gael
    Ames, David
    Szoeke, Cassandra
    Laws, Simon M.
    Verdile, Giuseppe
    Martins, Ralph N.
    Masters, Colin L.
    Rowe, Christopher C.
    [J]. NEUROPSYCHOLOGIA, 2011, 49 (09) : 2384 - 2390